Le Lézard
Classified in: Health
Subject: PER

Pharmacy Quality Solutions CEO Jeff Newell Announces Retirement


DURHAM, N.C., Oct. 19, 2020 /PRNewswire/ -- Jeff Newell, Chief Executive Officer of Pharmacy Quality Solutions (PQS), has announced his intent to retire at the end of May 2021. Newell's tenure at PQS serves as a capstone to his 40-year career in pharmacy.

"Pharmacy is in my blood," Newell said, noting that many of his family members are pharmacists. "It truly has been a pleasure to work side by side with my PQS team members, past and present, to build a business that supports our client's needs."

Newell has a long track record of leadership and quality improvement within multiple healthcare settings including community pharmacy, long-term care and within a quality improvement organization. Newell has grown PQS's strategy, team, financial stability, reach and influence.

"The board has enjoyed working with a leader with such deep industry knowledge," said Tom Menighan, APhA CEO Emeritus and chair of the PQS Board of Directors. He notes that Newell grew both the team and scope of the business, elevated the stature of the organization and increased marketplace relevance during his tenure. Furthermore, PQS is well-positioned to grow into new markets and be a catalyst to drive important changes in healthcare. "He will be missed," Menighan concluded, "but he leaves behind a high-performing team. We wish him well in his next chapter."

Before joining PQS in 2017, Newell served as an executive with Sears Holding, Millennium, Healthcentric Advisors and CVS Health. Areas of responsibility included strategy, joint ventures, partnerships, regulatory, compliance, managed care, patient engagement, quality measurement, specialty pharmacy and operations. Newell began his pharmacy career in family-owned and operated pharmacies in New York and was involved in various volunteer and appointed roles across the profession, including Chairman of the Rhode Island Board of Pharmacy, President of the Rhode Island Pharmacists Association, and several other national advisory boards.

Newell and the PQS board are executing a succession plan without business interruption to clients or staff. Todd Sega, PharmD, SVP, Development and Strategy, will succeed Newell.

About Pharmacy Quality Solutions, Inc.

Pharmacy Quality Solutions (PQS), is the leading provider of performance management services representing nearly 90% of Medicare lives and 95% of community pharmacies. PQS delivers the quality insights and guidance necessary to support its customers' efforts to optimize the quality of medication management and use for their Medicare, Medicaid and commercial populations. PQS connects medication use stakeholders to actionable, quality information in a consistent and reliable fashion, allowing them to move more quickly from measurement to improvement. Its industry-leading platform, EQuIPP®, provides dependable measurement and reporting on key medication use quality measures, including addressing medication adherence, gaps in care, and patient safety.  PQS provides measurement insights that are timely, actionable, and simply understood. For more information, please visit www.pharmacyquality.com.

For further information contact David Simoneaux at 919.864.9756 ext. 312 or [email protected].

Related Images

pharmacy-quality-solutions.png
Pharmacy Quality Solutions

SOURCE Pharmacy Quality Solutions, Inc.


These press releases may also interest you

at 03:00
ARTHEx Biotech S.L., a clinical-stage biotechnology company focused on developing innovative medicines through the modulation of microRNAs, today announced an oral presentation at the upcoming Oligonucleotide & Peptide Therapeutics (TIDES) Conference...

at 02:32
With every successive year, the lines between medical devices and consumer electronics become increasingly blurred ? medtech companies seek to expand their reach beyond patients, and consumer electronics companies have targeted medical applications...

18 avr 2024
The 31st Canadian Cancer Society (CCS) Daffodil Ball, which took place this evening at Windsor Station in Montreal, raised $1,474,785 to fund innovative research projects and essential support programs for people living with cancer. The largest...

18 avr 2024
The report titled "Clinical Trials Matching Software Market by Functionality (Analytics & Reporting, Compliance Tracking, Data Management), Deployment (Cloud & Web Based, On-Premise), End-Use - Global Forecast 2024-2030" is now available on...

18 avr 2024
South Korea's biotechnology company Hyundai Bioscience (CEO Oh Sang-gi, www.hyundaibioscience.com) announced on April 15 that it would carry out global clinical tests aimed at treating all serotypes of Dengue virus infection....

18 avr 2024
The report titled "Progressive Familial Intrahepatic Cholestasis Treatment Market by Drug Type (Cholestyramine, Rifampicin, Ursodeoxycholic Acid), Distribution Channel (Hospital Pharmacies, Online Pharmacies, Retail Pharmacies), End-Users - Global...



News published on and distributed by: